Download Citation
Article Source:
Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring
Wasserbauer M,
Hlava S,
Drabek J,
Stovicek J,
Minarikova P,
et al.
(2022)
Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring.
PLOS ONE 17(8): e0271299.
https://doi.org/10.1371/journal.pone.0271299